TLE1 and lung carcinoma: As a critical molecular event underlying lung cancer cell anoikis resistance, the TLE1-mediated repression of E-cadherin acted as a downstream target of the anoikis function of the tumor suppressor Bcl-2 inhibitor of transcription 1 (Bit1) [18, 19].